Meeting
2013 ASCO Annual Meeting
Testosterone (T), luteinizing hormone (LH), and follicle stimulating hormone (FSH) levels in testicular cancer survivors (TCSs) 11 and 19 years after orchiectomy.
Authors
Mette Sprauten
OUS, The Norwegian Radium Hospital, Oslo, Norway
Mette Sprauten , Marianne Brydoy , Hege Sagstuen Haugnes , Carl Wilhelm Langberg , Olav Dahl , Olbjorn Harald Klepp , Roy M. Bremnes , Milada Cvancarova , Sophie D. Fossa , Jan Oldenburg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer
Sub Track
Germ Cell/Testicular
Citation
J Clin Oncol 31, 2013 (suppl; abstr 4562)
DOI
10.1200/jco.2013.31.15_suppl.4562
Abstract #
4562
Poster Bd #
30F
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Longitudinal serum testosterone levels (T) in long-term testicular cancer survivors (TCSs) in relation to testicular cancer (TC) treatment, aging, and TC diagnosis itself.
First Author: Mette Sprauten
Poster
2022 ASCO Annual Meeting
Change in telomere length and cardiovascular risk in testicular cancer survivors.
First Author: Ellen L.D. Volders
Poster
2021 Genitourinary Cancers Symposium
Paternity, relationship, sexual activity and fertility in testicular cancer (TC) survivors (TCS): Results from a single institution observational prospective study.
First Author: Davide Bimbatti
Poster
2014 ASCO Annual Meeting
Impact of long-term serum platinum on neuro- and ototoxicity, cardiovascular disease, and hypogonadism in testicular cancer survivors.
First Author: Line veronika Hjelle